Table 3.
Decreased expression of genes from colonic biopsies in Crohn’s patients with loss of response to anti-TNFα therapy versus those who respond
| Gene | Fold Change | P-value | Adjusted P-value* | Rank** |
|---|---|---|---|---|
| FAM151A | −5.18 | 0.005 | 0.17 | 1 |
| CNTFR | −5.13 | 1.6 × 10−9 | 7.6 × 10−9 | 2 |
| SULT2A1 | −4.81 | 0.006 | 0.19 | 3 |
| G6PC | −4.39 | 0.0004 | 0.05 | 4 |
| CDHR1 | −3.30 | 0.0001 | 0.03 | 5 |
| TNC22 | −2.96 | 0.0003 | 0.05 | 6 |
| ESRRG | −2.40 | 0.0004 | 0.05 | 7 |
| SLC25A34 | −2.23 | 0.0004 | 0.05 | 8 |
| FZD7 | −2.14 | 9.1 × 10−5 | 0.03 | 9 |
| MYOM3 | −2.10 | 6.2 × 10−5 | 0.03 | 10 |
= Boneferroni corrected
= calculated by weighing of fold change and P-value